This is consistent with the current AD model, which suggests that Aβ pathology precedes tau pathology [3] and is a prerequisite for AD pathogenesis [178]; however, tau-dependent processes are needed for Aβ-mediated synaptic toxicity [179]. Here, MAPT is linked to Alzheimer disease.